.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Julphar
Cantor Fitzgerald
Merck
Teva
Harvard Business School
Express Scripts
UBS
Fuji
Federal Trade Commission

Generated: September 23, 2017

DrugPatentWatch Database Preview

HALDOL Drug Profile

« Back to Dashboard

Which patents cover Haldol, and when can generic versions of Haldol launch?

Haldol is a drug marketed by Janssen Pharms, Ortho Mcneil, and Ortho Mcneil Pharm. and is included in five NDAs.

The generic ingredient in HALDOL is haloperidol lactate. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the haloperidol lactate profile page.

Summary for Tradename: HALDOL

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list66
Clinical Trials: see list17
Patent Applications: see list9,073
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HALDOL at DailyMed

Pharmacology for Tradename: HALDOL

Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Janssen Pharms
HALDOL
haloperidol decanoate
INJECTABLE;INJECTION018701-001Jan 14, 1986AORXYesYes► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-006Feb 2, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
HALDOL
haloperidol decanoate
INJECTABLE;INJECTION018701-002Jan 31, 1997AORXYesYes► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
HALDOL
haloperidol lactate
INJECTABLE;INJECTION015923-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
HALDOL SOLUTAB
haloperidol
TABLET;ORAL017079-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HALDOL

Applicant Tradename Generic Name Dosage NDA >Approval Date Patent No. Patent Expiration
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Janssen Pharms
HALDOL
haloperidol lactate
INJECTABLE;INJECTION015923-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol lactate
CONCENTRATE;ORAL015922-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-006Feb 2, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
McKesson
Novartis
Mallinckrodt
UBS
Dow
Harvard Business School
Johnson and Johnson
McKinsey
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot